These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1429 related items for PubMed ID: 9331128

  • 41. Phase I dose-escalation trial of paclitaxel and ifosfamide in patients with advanced non-small cell lung cancer.
    Shepherd FA, Latreille J, Paul K, Eisenhauer E.
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):84-90. PubMed ID: 9007130
    [Abstract] [Full Text] [Related]

  • 42. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
    Kelly K, Pan Z, Wood ME, Murphy J, Bunn PA.
    Clin Cancer Res; 1999 Nov; 5(11):3419-24. PubMed ID: 10589753
    [Abstract] [Full Text] [Related]

  • 43. Preliminary analysis of a phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small cell lung cancer.
    Choy H, DeVore RF, Hande KR, Porter LL, Rosenblatt P, Yunus F, Schlabach L, Smith C, Shyr Y, LaPorte K, Johnson DH.
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-21-S12-26. PubMed ID: 9331115
    [Abstract] [Full Text] [Related]

  • 44. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
    Hitt R, Hornedo J, Colomer R, Mendiola C, Brandariz A, Sevilla E, Alvarez-Vicent J, Cortés-Funes H.
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971
    [Abstract] [Full Text] [Related]

  • 45. A sequence-dependent paclitaxel/etoposide phase II trial in patients with non-small cell lung cancer.
    Rosell R, Felip E, Massuti B, González-Larriba JL, Benito D, López-Cabrerizo MP, Salamanca O, Camps C, Puerto-Pica J.
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-56-S12-60. PubMed ID: 9331123
    [Abstract] [Full Text] [Related]

  • 46. A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.
    Herbst RS, Hammond LA, Carbone DP, Tran HT, Holroyd KJ, Desai A, Williams JI, Bekele BN, Hait H, Allgood V, Solomon S, Schiller JH.
    Clin Cancer Res; 2003 Sep 15; 9(11):4108-15. PubMed ID: 14519633
    [Abstract] [Full Text] [Related]

  • 47. Paclitaxel 3-hour infusion given alone and combined with carboplatin: preliminary results of dose-escalation trials.
    Muggia FM, Vafai D, Natale R, Israel V, Zaretsky S, McRae A, Rogers M, Jeffers S.
    Semin Oncol; 1995 Aug 15; 22(4 Suppl 9):63-6. PubMed ID: 7644931
    [Abstract] [Full Text] [Related]

  • 48. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
    Paccagnella A, Favaretto A, Oniga F, Festi G, Lauro S, Morabito A, Ossana L, Sartore F, DePoli F, Fiorentino MV.
    Cancer; 1996 Oct 15; 78(8):1701-7. PubMed ID: 8859183
    [Abstract] [Full Text] [Related]

  • 49. A phase I/randomized phase II, non-comparative, multicenter, open label trial of CP-547,632 in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC).
    Cohen RB, Langer CJ, Simon GR, Eisenberg PD, Hainsworth JD, Madajewicz S, Cosgriff TM, Pierce K, Xu H, Liau K, Healey D.
    Cancer Chemother Pharmacol; 2007 Jun 15; 60(1):81-9. PubMed ID: 17031646
    [Abstract] [Full Text] [Related]

  • 50. Pilot study with fixed-dose carboplatin and escalating paclitaxel in advanced ovarian cancer.
    Bolis G.
    Semin Oncol; 1995 Dec 15; 22(6 Suppl 14):32-4. PubMed ID: 8553081
    [Abstract] [Full Text] [Related]

  • 51. Phase II study of paclitaxel and cisplatin in patients with non-small cell lung cancer.
    von Pawel J, Wagner H, Niederle N, Heider A, Koschel G, Hecker D, Hanske M.
    Semin Oncol; 1996 Dec 15; 23(6 Suppl 16):47-50. PubMed ID: 9007121
    [Abstract] [Full Text] [Related]

  • 52. Single-agent paclitaxel by 3-hour infusion in the treatment of non-small cell lung cancer: links between p53 and K-ras gene status and chemosensitivity.
    Rosell R, González-Larriba JL, Alberola V, Molina F, Monzó M, Benito D, Pérez JM, de Anta JM.
    Semin Oncol; 1995 Dec 15; 22(6 Suppl 14):12-8. PubMed ID: 8553077
    [Abstract] [Full Text] [Related]

  • 53. A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer.
    Amadori D, Frassineti GL, Zoli W, Milandri C, Tienghi A, Ravaioli A, Gentile A, Salzano E.
    Semin Oncol; 1996 Oct 15; 23(5 Suppl 11):16-22. PubMed ID: 8893894
    [Abstract] [Full Text] [Related]

  • 54. Treatment of patients with upper gastrointestinal carcinomas.
    Ajani JA.
    Semin Oncol; 1997 Dec 15; 24(6 Suppl 19):S19-72-S19-76. PubMed ID: 9427271
    [Abstract] [Full Text] [Related]

  • 55. Carboplatin plus paclitaxel in the first-line treatment of advanced ovarian cancer: preliminary results of a phase I study.
    Lhommé C, Kerbrat P, Lejeune C, Guastalla JP, Fumoleau P, Goupil A, Héron JF, Cassin MA, Pruvot I, Soares JA, Chazard M.
    Semin Oncol; 1996 Oct 15; 23(5 Suppl 12):48-54. PubMed ID: 8941410
    [Abstract] [Full Text] [Related]

  • 56. Phase I study of paclitaxel as a 3-hour infusion followed by carboplatin in untreated patients with stage IV non-small cell lung cancer.
    Rowinsky EK, Flood WA, Sartorius SE, Bowling MK, Wagner J, Ettinger DS.
    Semin Oncol; 1995 Aug 15; 22(4 Suppl 9):48-54. PubMed ID: 7644928
    [Abstract] [Full Text] [Related]

  • 57. Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer (NSCLC): a preliminary study.
    Ratanatharathorn V, Jirajarus M, Sirachainan E, Sirilerttrakul S, Euaree A, Supatchaipisit P.
    J Med Assoc Thai; 1998 Oct 15; 81(10):763-71. PubMed ID: 9803067
    [Abstract] [Full Text] [Related]

  • 58. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
    Hainsworth JD, Greco FA.
    Semin Oncol; 1995 Dec 15; 22(6 Suppl 15):45-9. PubMed ID: 8643970
    [Abstract] [Full Text] [Related]

  • 59. Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study.
    Skarlos DV, Aravantinos G, Kosmidis P, Athanassiadis A, Stathopoulos GP, Pavlidis N, Bafaloukos D, Karphathios S, Papakostas P, Bamia C, Fountzilas G.
    Semin Oncol; 1997 Oct 15; 24(5 Suppl 15):S15-57-S15-61. PubMed ID: 9346224
    [Abstract] [Full Text] [Related]

  • 60. Paclitaxel, carboplatin, and oral etoposide: a phase II trial in limited-stage small cell lung cancer.
    Gatzemeier U, Jagos U, Kaukel E, Koschel G, von Pawel J.
    Semin Oncol; 1997 Aug 15; 24(4 Suppl 12):S12-149-S12-152. PubMed ID: 9331141
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 72.